Atara Biotherapeutics (ATRA) Other financing activities (2015 - 2025)
Atara Biotherapeutics (ATRA) posted Other financing activities of $36000.0 for Q4 2025, down 69.23% on a QoQ basis from $117000.0 in Q4 2024, and down 69.23% year-over-year from $117000.0 in Q4 2024.
Atara Biotherapeutics (ATRA) Other financing activities (2015 - 2025) Analysis & Trends
Atara Biotherapeutics' Other financing activities history runs 11 years deep, the most recent figure standing at $36000.0 for Q4 2025.
- Quarterly Other financing activities fell 69.23% year-over-year to $36000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $153000.0 (down 33.48% YoY) and the FY2025 annual result came in at $35000.0, down 84.78% from the prior year.
- Other financing activities was $36000.0 for Q4 2025 at Atara Biotherapeutics, down from $117000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $5.2 million in Q3 2021 and bottomed at -$5.2 million in Q4 2021.
- A 5-year average of $3384.6 and a median of $36000.0 in 2025 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2021 — Other financing activities surged 1160.0% — and 2022, when it plunged 129.96%.
- Atara Biotherapeutics' Other financing activities stood at -$5.2 million in 2021, then soared by 99.29% to -$37000.0 in 2022, then slumped by 1954.05% to -$760000.0 in 2023, then jumped by 115.39% to $117000.0 in 2024, then sank by 69.23% to $36000.0 in 2025.
- Business Quant data shows ATRA's Other financing activities at $36000.0 in Q4 2025, $117000.0 in Q4 2024, and $113000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 117,000.00 |
| Dec 31, 2024 | 117,000.00 |
| Jun 30, 2024 | 113,000.00 |
| Jun 30, 2024 | 113,000.00 |
| Sep 30, 2023 | -760,000.00 |
| Sep 30, 2023 | -760,000.00 |
| Jun 30, 2023 | 747,000.00 |
| Jun 30, 2023 | 747,000.00 |
| Dec 31, 2022 | -37,000.00 |
| Dec 31, 2022 | -37,000.00 |
| Sep 30, 2022 | -1.56 Mn |
| Sep 30, 2022 | -1.56 Mn |
| Jun 30, 2022 | 1.51 Mn |
| Jun 30, 2022 | 1.51 Mn |
| Mar 31, 2022 | -104,000.00 |
| Mar 31, 2022 | -104,000.00 |
| Dec 31, 2021 | -5.21 Mn |
| Dec 31, 2021 | -5.21 Mn |